Navigation Links
QRxPharma to Sponsor Symposium at 13th World Congress on Pain Meeting
Date:8/31/2010

r they are frequently of shorter duration among MoxDuo IR subjects than the controls.

According to a report published in 2006 in The British Journal of Pharmacology(1), the search for an analgesic that combines opioid-like efficacy without the well known adverse event profile associated with these drugs has been likened to that for the "Holy Grail" of pain therapy.  The rate of occurrence for nausea, vomiting, dizziness, sedation, and constipation, are estimated to occur in "tens of millions" of Americans suffering from acute and chronic pain every year(2).  Incremental costs to the health care system for GI events caused by opioids alone are estimated to range from $4,880 to $36,152 per patient(3).

Therefore, the ability of MoxDuo IR to markedly reduce the occurrence of moderate-severe AEs has important clinical and economic benefits.  Having demonstrated reductions of 50%-75% of adverse events, MoxDuo IR opens the therapeutic window for acute pain patients suffering from moderate to severe pain and provides the potential for significant healthcare cost reductions in the treatment of patients receiving opioid therapy.

About QRxPharma

QRxPharma (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of new treatments for pain management and central nervous system (CNS) disorders. Based on a development strategy which focuses on enhancing and expanding the clinical utility of currently marketed compounds, the Company's product portfolio includes both late and early stage clinical drug candidates with the potential for reduced risk, abbreviated development paths, and improved patient outcomes.  The Company intends to directly commercialise its products in the US and seek strategic partnerships for worldwide markets.  QRxPharma's lead product candidate, MoxDuo®IR, is in Phase 3 clinical development and has successfully compl
'/>"/>

SOURCE QRxPharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
4. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
5. QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
6. QRxPharma Limited Announces A$21.6 Million Fully Underwritten Capital Raising
7. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
8. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
9. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
10. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
11. QRxPharma Receives Positive Feedback from Scientific Advice Meetings in Europe on MoxDuo®IR Development and Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 "Whether it,s our family, ... day." In a single sentence, Dr. ... officer at Pfizer,s Centers for Therapeutic Innovation ... fueling progress at America,s biopharmaceutical companies. ... with academia, patient foundations and the National Institutes of ...
(Date:3/26/2015)... 26, 2015 When they began experiencing ... PACS vendor their system would no longer be ... needed a better structured solution to support their ... due to its interface capabilities and its 2014 ... through to the hospital,s radiology department. Avreo,s experienced ...
(Date:3/26/2015)... 26, 2015 Zimmer Holdings, Inc. (NYSE and ... Advanced Bearing Technology with Vitamin E by celebrating ... earlier this month reported that, at 96 million cycles ... Bearing Technology featuring Vitamin E grafted highly crosslinked polyethylene ... rate reduction of 95 percent, with no cracking, delamination ...
Breaking Medicine Technology:Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
... Ferring Pharmaceuticals Inc. today announced publication of one ... (tranexamic acid) tablets for cyclic heavy menstrual bleeding ... journal, Obstetrics & Gynecology .  The six-month ... blood loss from baseline, and improved health-related quality-of-life ...
... Oct. 6 AstraZeneca (NYSE: AZN ... at no cost to qualifying patients at the ... (Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) ... is an expansion of its AZ&Me™ Prescription Savings ...
Cached Medicine Technology:Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 2Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 3Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 4AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients 2AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients 3
(Date:3/26/2015)... March 26, 2015 Dr. Rod ... annual Dallas Rhinoplasty Symposium and has trained over ... the importance of evidence based medicine (EBM), that is, ... well conducted research. , "We often hear from ... and while we are certainly not trying to stifle ...
(Date:3/26/2015)... North American Seminars launches it new mobile website ... information regarding OT PT continuing education courses to the ... leader in live hands PT continuing education courses ... online continuing education courses. , Featured Live ... Clinicians Approach to Advanced Concepts in Examination and Treatment ...
(Date:3/26/2015)... 2015 The American College of Traditional Chinese ... topics of the DAOM Program as well as Marketing Basics ... will be hosted by Dr. Carla Wilson, who will give ... on how to prepare for the spring quarter. The webinar ... 27, April 1 and April 3. Attendees can log in ...
(Date:3/26/2015)... Doctors Scott Sullivan and Frank DellaCroce, Co-Founders of the ... the St. Charles Surgical Hospital (SCSH) in ... Surgical Oncologist Dr. William Karl Ordoyne has joined their ... surgical oncologist Alan Stolier, M.D., FACS and the team ... Sullivan, M.D., FACS; Chris Trahan, M.D., FACS; M. Whitten ...
(Date:3/26/2015)... Doylestown, PA (PRWEB) March 26, 2015 ... recruited a new team of nationally renowned scientists to ... hepatitis B, a move that nearly triples its research ... scientists focusing solely on hepatitis B and liver cancer ... Drs. Timothy Block, Jinhong Chang, Ju Tao Guo and ...
Breaking Medicine News(10 mins):Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3Health News:ACTCM Announces Upcoming Webinars 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 2Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 4
... study published in the Lancet has revealed how British American ... strategy to mask the toxicity of the manufactured cigarettes. // ... of the company by Canadian researchers, it has been found ... nicotine under real life situations, while in documentation, it was ...
... at the University of Iowa Roy J. and Lucille A. ... (PET) technology can help // doctors gauge the response of ... and co-author Bruce Cheson, M.D., of the Lombardi Comprehensive Cancer ... usage of PET n gauging the response of the tumor ...
... service policy acceptance in schools it has been found ... directors' perceptions. // ,They have different ideas ... among key stakeholders addressing new wellness policy development mandated ... 2004. ,'Competitive foods are those sold ...
... respiratory illness as a result of breast-feeding, according to a ... belonging to the age group of 6 years to 24 ... They identified five groups, formula-fed only, full breastfeeding for ... months, full breastfeeding from four to less than six months, ...
... the wrong reasons. Blaming the government of apathy over the ... post of Chief Scientific Officer at the Department of Health, has ... vaccine adequately, despite a lurking fear of autism, as a probable ... it could turn out to be the worst disgrace in medical ...
... Health Grade, a health ratings company, the top 5 % ... to lower the risk of death to patients by ... risk of complications. //,Health Grades, as part of their ... in the United States. ,Death and complication rates for ...
Cached Medicine News:Health News:Clash of Difference of perceptions in food policy among Principals’ and Director 2
... One of the most innovative and ... Thermotherapy (WIT) provides an ideal solution for ... office. No other option provides a better ... The AquaTherm System heats, circulates, and maintains ...
... generally confirmed by a positive heterophil antibody test ... not indicated by the heterophil antibody test. ... percent of children. Detection and identification of ... the stage of EBV infection. Bio-Rad offers ...
... Every Bard® Biopsy Instrument and Needle is ... important goal: a large quality, reliable core ... performance, featuring ultra-sharp tips and polished surfaces ... selection of biopsy systems and needle sizes ...
... Used to obtain multiple core biopsies ... Quick-Core® Biopsy Needle design facilitates one-handed control. ... tissue sample. Beveled point stylet permits easy ... to surrounding tissue. Sharp cutting edge of ...
Medicine Products: